|
|
||||||||
a Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 578, Grenoble, France;
b Centre dInvestigation Biologique, Centre Hospitalier Universitaire, Grenoble, France;
c Institut National de la Santé et de la Recherche Médicale (Inserm), Unité 371, Institut Fédératif des Neurosciences de Lyon, Bron, France;
d Laboratoire de Biologie Moléculaire de la Cellule, CNRS UMR 5161, Ecole Normale Supérieure de Lyon, France;
e Cell Isolation and Transplantation Center, University of Geneva Medical Center, Geneva, Switzerland;
f Département dEndocrinologie, Centre Hospitalier Universitaire, Grenoble, France
Key Words. Bone marrow • Mesenchymal stem cell • Pancreatic beta cell • Cell differentiation • Insulin • Transcription factors
Correspondence: Pierre-Yves Benhamou, M.D., Ph.D, Centre dInvestigation Biologique, Pavillon B, Centre Hospitalier Universitaire, 38043 Grenoble Cedex 9, France. Telephone: 33-4-76-76-88-56; Fax: 33-4-76-76-50-42; e-mail: pierre-yves.benhamou{at}wanadoo.fr
Multipotential stem cells can be selected from the bone marrow by plastic adhesion, expanded, and cultured. They are able to differentiate not only into multiple cell types, including cartilage, bone, adipose and fibrous tissues, and myelosupportive stroma, but also into mesodermal (endothelium), neuroectodermal, or endodermal (hepatocytes) lineages. Our goal was to characterize the multipotential capacities of human mesenchymal stem cells (hMSCs) and to evaluate their ability to differentiate into insulin-secreting cells in vitro. hMSCs were obtained from healthy donors, selected by plastic adhesion, and phenotyped by fluorescence-activated cell sorter and reverse transcriptionpolymerase chain reaction analysis before and after infection with adenoviruses coding for mouse IPF1, HLXB9, and FOXA2 transcription factors involved early in the endocrine developmental pathway. We found that native hMSCs have a pluripotent phenotype (OCT4 expression and high telomere length) and constitutively express NKX6-1 at a low level but lack all other transcription factors implicated in beta-cell differentiation. In all hMSCs, we detected mRNA of cytokeratin 18 and 19, epithelial markers present in pancreatic ductal cells, whereas proconvertase 1/3 mRNA expression was detected only in some hMSCs. Ectopic expression of IPF1, HLXB9, and FOXA2 with or without islet coculture or islet-conditioned medium results in insulin gene expression. In conclusion, our results demonstrated that in vitro human bone marrow stem cells are able to differentiate into insulin-expressing cells by a mechanism involving several transcription factors of the beta-cell developmental pathway when cultured in an appropriate microenvironment.
This article has been cited by other articles:
![]() |
B. Davani, L. Ikonomou, B. M. Raaka, E. Geras-Raaka, R. A. Morton, B. Marcus-Samuels, and M. C. Gershengorn Human Islet-Derived Precursor Cells Are Mesenchymal Stromal Cells That Differentiate and Mature to Hormone-Expressing Cells In Vivo Stem Cells, December 1, 2007; 25(12): 3215 - 3222. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mutskov, B. M. Raaka, G. Felsenfeld, and M. C. Gershengorn The Human Insulin Gene Displays Transcriptionally Active Epigenetic Marks in Islet-Derived Mesenchymal Precursor Cells in the Absence of Insulin Expression Stem Cells, December 1, 2007; 25(12): 3223 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Karnieli, Y. Izhar-Prato, S. Bulvik, and S. Efrat Generation of Insulin-Producing Cells from Human Bone Marrow Mesenchymal Stem Cells by Genetic Manipulation Stem Cells, November 1, 2007; 25(11): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Chase, F. Ulloa-Montoya, B. L. Kidder, and C. M. Verfaillie Islet-Derived Fibroblast-Like Cells Are Not Derived via Epithelial-Mesenchymal Transition From Pdx-1 or Insulin-Positive Cells Diabetes, January 1, 2007; 56(1): 3 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kern, H. Eichler, J. Stoeve, H. Kluter, and K. Bieback Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue Stem Cells, May 1, 2006; 24(5): 1294 - 1301. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
